Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P0
Near historical low
vs 2Y Ago
-169.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -53.69 | -1010.5% |
| 2024 | -4.83 | -1624.3% |
| 2023 | 0.32 | +441.4% |
| 2022 | -0.09 | +98.0% |
| 2021 | -4.72 | -11.5% |
| 2020 | -4.23 | -42.4% |
| 2019 | -2.97 | -0.6% |
| 2018 | -2.96 | -17.4% |
| 2017 | -2.52 | -1163.2% |
| 2016 | 0.24 | - |